NISA INVESTMENT ADVISORS, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,688
+84300.0%
6780.0%0.00%
Q1 2023$2
-50.0%
6780.0%0.00%
Q4 2022$4
-99.9%
6780.0%0.00%
Q3 2022$7,000
+133.3%
6780.0%0.00%
Q2 2022$3,000
-81.2%
678
-67.4%
0.00%
Q1 2022$16,000
+128.6%
2,078
+206.5%
0.00%
Q4 2021$7,000
-61.1%
678
-50.8%
0.00%
Q3 2021$18,000
-40.0%
1,3780.0%0.00%
Q2 2021$30,000
-9.1%
1,3780.0%0.00%
Q1 2021$33,000
+32.0%
1,3780.0%0.00%
Q4 2020$25,000
+400.0%
1,378
+222.0%
0.00%
Q3 2020$5,000
-50.0%
4280.0%0.00%
Q2 2020$10,000
+100.0%
4280.0%0.00%
Q1 2020$5,000
-28.6%
428
+59.7%
0.00%
Q4 2019$7,000
-98.8%
268
-98.9%
0.00%
-100.0%
Q3 2019$576,000
+3740.0%
25,268
+4953.6%
0.01%
Q2 2019$15,000
+650.0%
500
+233.3%
0.00%
Q1 2019$2,000
-33.3%
1500.0%0.00%
Q4 2018$3,000
-62.5%
1500.0%0.00%
Q3 2018$8,0001500.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 994,287$19,041,0001.55%
HHLR ADVISORS, LTD. 949,431$18,182,0000.75%
BB BIOTECH AG 671,925$12,867,0000.41%
Rhenman & Partners Asset Management AB 172,820$3,310,0000.38%
Birchview Capital, LP 15,000$287,0000.27%
Rock Springs Capital Management LP 100,000$1,915,0000.09%
SECOR Capital Advisors, LP 32,591$624,0000.08%
MARSHALL WACE, LLP 386,510$7,402,0000.08%
SIGNATUREFD, LLC 37,942$727,0000.07%
A.R.T. Advisors, LLC 38,125$730,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders